NOV 16, 2019 06:39 AM PST

Understanding H. pylori and gastric cancer

New research published in the journal Gastroenterology offers insight on gastric cancer and the presence of the common bacteria known as H. pylori (Helicobacter pylori). Although previous studies have investigated the impacts that H. pylori have on the gut, researchers from the Perelman School of Medicine at the University of Pennsylvania now confirm that eliminating H. pylori from the gastrointestinal tract can cut the risk of gastric cancer by 75% in the US.

The study was conducted by lead author Shria Kumar, MD, and fellow researchers. Kumar commented, "The problem was that all research out of the U.S. used to study gastric cancer and determine American's risk of developing it did not take into account H. pylori infection, and studies worldwide have shown this infection is actually the leading risk factor for this type of cancer.”

The research team analyzed data from 400,000 patients to conclude that the link between the incidence of gastric cancer and H. pylori is stronger in certain populations – for instance, African American, Asian, Hispanic and Latinx, American Indian and Inuit American populations. They also saw an increased risk of H. pylori and consequential gastric cancer in men, smokers, and older individuals. This finding suggests that certain populations would benefit from increased monitoring for the bacteria.

"Discovering that these particular racial and ethnic groups are more likely to develop cancer after detection of this bacteria could influence clinicians' future screening practices and hopefully lead to early detection and management of gastric cancer," explained Kumar.

Detecting H. pylori can be tedious, involving multiple detection methods. Photo: Suburban Gastroenterology

Detecting and treating H. pylori is tedious and involves an endoscopic procedure, breath test, or stool sample. Many times, treatment procedures are not successful in fully eliminating the bacteria from the gastrointestinal tract, making follow-up care crucial. Yet, while an estimated 50% of the world’s population “suffers” from H. pylori, the bacteria are tricky because many may not suffer from symptoms at all, and thus likely unaware of its presence.

"According to estimates, there will be 27,000 new cases of gastric cancer in the U.S. this year, which is small compared to the prevalence of colorectal cancer -- for which there are an estimated 101,000 new cases for 2019," said Kumar. "It's not feasible or necessary to screen everyone for H. pylori or gastric cancer, but our study suggests that certain people may have high enough compounding risk to warrant regular invasive screenings and anyone treated for an H. pylori infection should be assessed to ensure eradication of the bacteria." The authors are quick to assure that even for those in the US that have contracted H. pylori, most do not develop gastric cancer.

Sources: Gastroenterology, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
DEC 11, 2019
Health & Medicine
DEC 11, 2019
A Skin Patch Might be the Most Effective Melanoma Treatment
Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medicati...
DEC 11, 2019
Cancer
DEC 11, 2019
Can eating mushrooms reduce the risk of prostate cancer?
Now here’s a question: have you eaten your mushrooms yet today? Although mushrooms may not be one of the typically-touted snacks in the healthcare wo...
DEC 11, 2019
Cell & Molecular Biology
DEC 11, 2019
Stem Cell Derived Natural Killer T Cells as Novel and Long-term Cancer Treatment
Hematopoietic stem cells are used to create a population of Natural Killer T-cells that could sustain and renew within the immune system, and attack cancer cells....
DEC 11, 2019
Genetics & Genomics
DEC 11, 2019
Breast Cancer Drug Increases Survival for Prostate Cancer Patients
A breast cancer drug is better at treating advanced prostate cancer in some men than current therapies, a clinical trial shows....
DEC 11, 2019
Drug Discovery & Development
DEC 11, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
DEC 11, 2019
Drug Discovery & Development
DEC 11, 2019
The Side-Effects to A Common Blood Cancer Drug
In a study published in Scientific Reports, a popular cancer drug, known as ruxolitnib, was found to cause an increased weight gain as well as an increase ...
Loading Comments...